Ranitidine
Product Images NDC 33358-316

2 FDA label images from Rxchange Co. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 33358-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4ed1b591 Figure 01)

Chemical Structure (4ed1b591 Figure 01)
Chemical structure of ranitidine showing its molecular components, including aromatic rings, nitrogen-containing groups, and an associated acid moiety.*
FDA Label Image

Ranitidine150mg (Ranitidine150mg)

Ranitidine150mg (Ranitidine150mg)
Ranitidine HCl 150mg tablet bottle label from RxChange Co., NDC 33358-316-30. The label indicates a bottle of 30 tablets with orange, round, biconvex, film-coated tablets. The label includes storage instructions, manufacturer information (Amneal Pharmaceuticals of NY), and regulatory details. The bottle is a tight/light resistant container intended for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.